Cargando…
Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID
OBJECTIVE: Musculoskeletal (MSK) pain is being increasingly reported by patients as one of the most common persistent symptoms in post-COVID-19 syndrome or Long COVID. However, there is a lack of understanding of its prevalence, characteristics, and underlying pathophysiological mechanisms. The obje...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212788/ https://www.ncbi.nlm.nih.gov/pubmed/35747600 http://dx.doi.org/10.2147/JPR.S365026 |
_version_ | 1784730686115020800 |
---|---|
author | Khoja, Omar Silva Passadouro, Bárbara Mulvey, Matthew Delis, Ioannis Astill, Sarah Tan, Ai Lyn Sivan, Manoj |
author_facet | Khoja, Omar Silva Passadouro, Bárbara Mulvey, Matthew Delis, Ioannis Astill, Sarah Tan, Ai Lyn Sivan, Manoj |
author_sort | Khoja, Omar |
collection | PubMed |
description | OBJECTIVE: Musculoskeletal (MSK) pain is being increasingly reported by patients as one of the most common persistent symptoms in post-COVID-19 syndrome or Long COVID. However, there is a lack of understanding of its prevalence, characteristics, and underlying pathophysiological mechanisms. The objective of this review is to identify and describe the features and characteristics of MSK pain in Long COVID patients. METHODS: The narrative review involved a literature search of the following online databases: MEDLINE (OVID), EMBASE (OVID), CINAHL, PsyclNFO, and Web of Science (December 2019 to February 2022). We included observational studies that investigated the prevalence, characteristics, risk factors and mechanisms of MSK pain in Long COVID. After screening and reviewing the initial literature search results, a total of 35 studies were included in this review. RESULTS: The overall reported prevalence of MSK pain in Long COVID ranged widely from 0.3% to 65.2%. The pain has been reported to be localized to a particular region or generalized and widespread. No consistent pattern of progression of MSK pain symptoms over time was identified. Female gender and higher BMI could be potential risk factors for Long COVID MSK pain, but no clear association has been found with age and ethnicity. Different pathophysiological mechanisms have been hypothesized to contribute to MSK pain in Long COVID including increased production of proinflammatory cytokines, immune cell hyperactivation, direct viral entry of neurological and MSK system cells, and psychological factors. CONCLUSION: MSK pain is one of the most common symptoms in Long COVID. Most of the current literature on Long COVID focuses on reporting the prevalence of persistent MSK pain. Studies describing the pain characteristics are scarce. The precise mechanism of MSK pain in Long COVID is yet to be investigated. Future research must explore the characteristics, risk factors, natural progression, and underlying mechanisms of MSK pain in Long COVID. |
format | Online Article Text |
id | pubmed-9212788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92127882022-06-22 Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID Khoja, Omar Silva Passadouro, Bárbara Mulvey, Matthew Delis, Ioannis Astill, Sarah Tan, Ai Lyn Sivan, Manoj J Pain Res Review OBJECTIVE: Musculoskeletal (MSK) pain is being increasingly reported by patients as one of the most common persistent symptoms in post-COVID-19 syndrome or Long COVID. However, there is a lack of understanding of its prevalence, characteristics, and underlying pathophysiological mechanisms. The objective of this review is to identify and describe the features and characteristics of MSK pain in Long COVID patients. METHODS: The narrative review involved a literature search of the following online databases: MEDLINE (OVID), EMBASE (OVID), CINAHL, PsyclNFO, and Web of Science (December 2019 to February 2022). We included observational studies that investigated the prevalence, characteristics, risk factors and mechanisms of MSK pain in Long COVID. After screening and reviewing the initial literature search results, a total of 35 studies were included in this review. RESULTS: The overall reported prevalence of MSK pain in Long COVID ranged widely from 0.3% to 65.2%. The pain has been reported to be localized to a particular region or generalized and widespread. No consistent pattern of progression of MSK pain symptoms over time was identified. Female gender and higher BMI could be potential risk factors for Long COVID MSK pain, but no clear association has been found with age and ethnicity. Different pathophysiological mechanisms have been hypothesized to contribute to MSK pain in Long COVID including increased production of proinflammatory cytokines, immune cell hyperactivation, direct viral entry of neurological and MSK system cells, and psychological factors. CONCLUSION: MSK pain is one of the most common symptoms in Long COVID. Most of the current literature on Long COVID focuses on reporting the prevalence of persistent MSK pain. Studies describing the pain characteristics are scarce. The precise mechanism of MSK pain in Long COVID is yet to be investigated. Future research must explore the characteristics, risk factors, natural progression, and underlying mechanisms of MSK pain in Long COVID. Dove 2022-06-17 /pmc/articles/PMC9212788/ /pubmed/35747600 http://dx.doi.org/10.2147/JPR.S365026 Text en © 2022 Khoja et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Khoja, Omar Silva Passadouro, Bárbara Mulvey, Matthew Delis, Ioannis Astill, Sarah Tan, Ai Lyn Sivan, Manoj Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID |
title | Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID |
title_full | Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID |
title_fullStr | Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID |
title_full_unstemmed | Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID |
title_short | Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID |
title_sort | clinical characteristics and mechanisms of musculoskeletal pain in long covid |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212788/ https://www.ncbi.nlm.nih.gov/pubmed/35747600 http://dx.doi.org/10.2147/JPR.S365026 |
work_keys_str_mv | AT khojaomar clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid AT silvapassadourobarbara clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid AT mulveymatthew clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid AT delisioannis clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid AT astillsarah clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid AT tanailyn clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid AT sivanmanoj clinicalcharacteristicsandmechanismsofmusculoskeletalpaininlongcovid |